Mark Poritz
Chief Tech/Sci/R&D Officer bei CO-DIAGNOSTICS, INC.
Profil
Mark Poritz is currently the Chief Scientific Officer at Co-Diagnostics, Inc. He was previously the Chief Scientific Officer at Idaho Molecular, Inc. He holds a doctorate degree from the University of California and an undergraduate degree from Harvard College.
Aktive Positionen von Mark Poritz
| Unternehmen | Position | Beginn |
|---|---|---|
| CO-DIAGNOSTICS, INC. | Chief Tech/Sci/R&D Officer | 01.11.2022 |
Ehemalige bekannte Positionen von Mark Poritz
| Unternehmen | Position | Ende |
|---|---|---|
Idaho Molecular, Inc.
 Idaho Molecular, Inc. BiotechnologyHealth Technology Part of Co-Diagnostics, Inc., Idaho Molecular, Inc. is a biotechnology company that develops molecular diagnostics test devices. The private company is based in South Salt Lake, UT. The CEO of the company is Kirk M. Ririe. Idaho Molecular was acquired by Co-Diagnostics, Inc. on December 31, 2021. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Mark Poritz
| University of California | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CO-DIAGNOSTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Idaho Molecular, Inc.
Idaho Molecular, Inc. BiotechnologyHealth Technology Part of Co-Diagnostics, Inc., Idaho Molecular, Inc. is a biotechnology company that develops molecular diagnostics test devices. The private company is based in South Salt Lake, UT. The CEO of the company is Kirk M. Ririe. Idaho Molecular was acquired by Co-Diagnostics, Inc. on December 31, 2021. | Health Technology |
